12 Best Extremely Profitable Stocks to Buy Right Now

Page 10 of 11

2. Genmab A/S (NASDAQ:GMAB)

TTM Net Profit Margin: 35.23%

Number of Hedge Fund Holders: 20

Analyst Upside Potential: 45.18%

Genmab A/S (NASDAQ:GMAB) is one of the Best Extremely Profitable Stocks to Buy Right Now. On July 16, Genmab A/S (NASDAQ:GMAB) announced new sales figures for DARZALEX as of the second quarter of 2025.

The company reported that the total worldwide sales reached $3.539 billion. Out of this, the US sales accounted for $2.017 billion, whereas sales from the rest of the world reached $1.521 billion. Management noted that the DARZALEX includes both intravenous and subcutaneous forms. Moreover, Genmab A/S (NASDAQ:GMAB) does not sell DARZALEX directly; instead, Johnson & Johnson (NYSE:JNJ) holds the exclusive license to develop and commercialize the drug, and the company receives royalties based on the sales.

Genmab A/S (NASDAQ:GMAB) is a biotechnology company from Denmark that develops antibody-based medicines to treat cancer and other diseases.

Page 10 of 11